title: Ballantyne syndrome and congenital anaemia associated with Parvovirus B19 infection: case report and review.
abstract: Acute maternal Parvovirus B19 infection affects about 1% of all pregnancies worldwide. Diaplacental transmission of Parvovirus B19 during the second trimester can cause complications like foetal hydrops, premature delivery or foetal loss in about 20-30% of these pregnancies, whereas the majority of maternal infections remain clinically silent. In individual cases, foetoplacental hydrops (of various origins) can trigger a rare form of Preeclampsia in the pregnant woman. The developing maternal oedema in this situation apparently "mirrors" the hydropic state of the foetus. The symptom triad of foetal hydrops, foetoplacental oedema and maternal anasarca defines Ballantyne syndrome. We report a case of Parvovirus-induced Ballantyne syndrome including a 10-year follow-up of mother and child. While the mother recovered rapidly after (preterm) delivery, the infection complicated the first months of life of the neonate. Congenital transfusion-dependent red cell aplasia and cholestatic hepathopathy took a chronic course but resolved under IVIG treatment. Follow-up now finds both the former neonate and the mother entirely recovered. Current knowledge on Ballantyne syndrome as well as perigestational Parvovirus infections including congenital anaemia is briefly reported and pathophysiological hypotheses are discussed.
authors.affiliation: Klinik für Kinder- und Jugendmedizin, Sektion Neonatologie, Universitätsklinikum Aachen, Aachen, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Schoberer
authors.forename: A
authors.initials: A
authors.lastname: Rink
authors.forename: W
authors.initials: W
authors.lastname: Rath
authors.forename: T
authors.initials: T
authors.lastname: Orlikowsky
mesh_terms: D000328:Adult; D000740:Anemia / Q000151:congenital* / Q000175:diagnosis* / Q000628:therapy / Q000821:virology; D003937:Diagnosis, Differential; D016731:Erythema Infectiosum / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000175:diagnosis* / Q000628:therapy / Q000821:virology; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000628:therapy; D011247:Pregnancy; D013577:Syndrome; D016896:Treatment Outcome